Bambusa Therapeutics Inc. develops bispecific antibodies for treating immunological and inflammatory disorders.

Atrandi Biosciences specializes in single-cell analysis technology, providing advanced microfluidic devices and high-throughput screening platforms.

Passkey Therapeutics develops novel therapies that target rare protein combinations to treat complex diseases like cancer and autoimmune disorders.